Chiesi Global Rare Diseases Launches " Rethink Acromegaly " Campaign to Provide Important Disease Education and Support to the Acromegaly Community
Rethink Acromegaly is created by Chiesi and members of the acromegaly community to help people living with the condition, along with their caregivers and families, to make informed healthcare decisions Program includes resources for healthcare professionals to optimize disease management to…#rethinkacromegaly #chiesi #boston #chiesigroup #rethinkacromegalycom #acromegaly #giacomochiesi #jillsisco #acromegalycommunity #globalrarediseases (Source: Reuters: Health)
Source: Reuters: Health - March 1, 2024 Category: Consumer Health News Source Type: news

Camurus Submits New Drug Application to the US FDA for Oclaiz for Treatment of Acromegaly
Lund, Sweden— 21 December 2023— Camurus (NASDAQ STO: CAMX) today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for OclaizTM (CAM2029), the company’s investigational,... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 21, 2023 Category: Drugs & Pharmacology Source Type: news

Camurus Submits New Drug Application to the US FDA for Oclaiz ™ for Treatment of Acromegaly
Lund, Sweden— 21 December 2023— Camurus (NASDAQ STO: CAMX) today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for OclaizTM (CAM2029), the company’s investigational,... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 21, 2023 Category: Drugs & Pharmacology Source Type: news

Endocrine Diseases-Focused Crinetics Pharmaceuticals Highlights Favorable Initial Findings From Mid-Stage Study
Crinetics Pharmaceuticals Inc CRNX released initial findings from its ongoing open-label Phase 2 carcinoid syndrome (CS) study of paltusotine, an oral, once-daily investigational compound being developed for acromegaly and CS. Carcinoid syndrome occurs when a rare cancerous tumor, called a…#phase2 #scottstruthers #crinetics #fda #enrollment (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2023 Category: Consumer Health News Source Type: news

Elevated IGF-1 in Patients Without Evidence of Acromegaly Elevated IGF-1 in Patients Without Evidence of Acromegaly
This study has identified the presence of elevated IGF-1 in certain people without clinically suspected acromegaly. What factors may contribute to these abnormal levels?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 13, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Presley's Bariatric Complication; Acromegaly Win; Tele-Monitor Diabetic Foot Ulcers
(MedPage Today) -- An autopsy report showed that Lisa Marie Presley, the only child of Elvis Presley, died of a small-bowel obstruction "caused by adhesions that developed after bariatric surgery years ago." (NBC News) Treatment with the investigational... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 18, 2023 Category: Endocrinology Source Type: news

The Effect of Mindfulness Therapy in Acromegaly The Effect of Mindfulness Therapy in Acromegaly
What benefits might patients with acromegaly gain from mindfulness therapy?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 20, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Acromegaly: Developing Drugs for Treatment
Acromegaly: Developing Drugs for Treatment (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 30, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Medical Treatments and Surgical Approaches for Acromegaly Medical Treatments and Surgical Approaches for Acromegaly
A new review looks at the currently available evidence for the use of preoperative medications and different surgical approaches to the treatment of acromegaly.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Acromegaly Prevalence is Higher Than Previously Reported Acromegaly Prevalence is Higher Than Previously Reported
An analysis of cases of acromegaly during recent decades finds a higher prevalence than previously thought. What may account for the difference in the data?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 22, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Preoperative Medical Treatment for Acromegaly: Yes or No? Preoperative Medical Treatment for Acromegaly: Yes or No?
Should acromegaly patients receive medical treatment prior to undergoing transsphenoidal surgery? A new review looks at the benefits and drawbacks.Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 20, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Efficacy of Lanreotide 120 mg Primary Therapy in Acromegaly Efficacy of Lanreotide 120 mg Primary Therapy in Acromegaly
Learn more about the clinical benefits of lanreotide as a primary treatment for patients with acromegaly.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 28, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

FDA Halts Diabetes Cell Tx Trial; Europe's Obesity Epidemic; Acromegaly Fractures
(MedPage Today) -- The FDA placed a clinical hold on Vertex's investigational diabetes cell therapy VX-880, saying the company didn't have enough evidence to support a treatment dose increase. (Fierce Biotech) A study from England found that surgeons... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 4, 2022 Category: Endocrinology Source Type: news

Indices of Glucose Homeostasis in Controlled Acromegaly Indices of Glucose Homeostasis in Controlled Acromegaly
Glucose and lipid profile improvements were associated with lower IGF-1 levels in patients with controlled acromegaly, regardless of treatment type.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 16, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Sex Differences in Acromegaly at Diagnosis Sex Differences in Acromegaly at Diagnosis
A new study examines the gender differences that exist in acromegaly. What are the implications?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 22, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news